Bernadett Kiralyne Kemenes
Introduction
Bernadett Kiralyne Kemenes is a registered nurse whose suspension was extended by six months by the Nursing and Midwifery Council (NMC) on 7 September 2026, after a Fitness to Practise Committee review panel found she had shown no new evidence of improved practice since her original hearing. The underlying findings were serious: that Kemenes gave a patient 32 units of insulin when eight had been prescribed — four times the dose — and then dishonestly amended medication records to conceal the error. The review panel found continuing impairment, a continuing risk of repetition, and no workable alternative to further suspension .
Background Information
The original case against Kemenes rested on two connected findings: a medication error, and what she did afterwards. The panel at the original hearing found proved that she administered 32 units of insulin instead of the prescribed eight units, and that she then dishonestly amended the medication records to conceal that error. The dishonesty finding is what separated the case from an ordinary medication-error case: the regulator’s concern was not only the tenfold overdose but the falsification designed to hide it .
A suspension order followed. The September 2026 hearing was a review of that order — the panel’s task being to decide whether the concerns that produced it had been addressed .
The Controversy or Incident That Led to Their Cancellation
Adjudicated (regulatory). The original findings were made by an NMC panel on the balance of probabilities — a civil standard, not a criminal conviction; the 2026 hearing reviewed the resulting order.
The insulin error sat at the dangerous end of nursing mistakes. Insulin is a high-alert medication, and a 32-unit dose against an eight-unit prescription is a fourfold overdose with the potential for severe hypoglycaemia. The proved dishonesty finding meant the error was compounded by records altered to conceal it, which is the combination most likely to end a nurse’s registration if unremediated .
The review panel found no basis to soften the order. It recorded that it had no new information or evidence of strengthened practice, found continuing impairment on both public-protection and public-interest grounds, and found a continuing risk of repetition. Conditions of practice were rejected as unworkable in light of Kemenes’s non-engagement with the process. It extended the suspension by six months, effective at the end of 14 October 2026, to allow time for reflection and work addressing the concerns .
The arithmetic of the case is stark: a nurse found to have covered up a fourfold insulin overdose has now been suspended, reviewed, and suspended again without producing evidence of a single completed step towards remediation .
Public Reaction and Consequences
The consequence of the 2026 review is the six-month extension, which keeps Kemenes off the register into 2027 on the current order. No wider public controversy attaches to the case in the fetched record; the visible consequences are the regulatory ones, recorded on the listing of 2026 NMC suspensions .
The panel’s findings leave little room for a favourable reading: continuing impairment on both limbs, continuing risk of repetition, and non-engagement sufficient to make conditions unworkable. In NMC practice, non-engagement at review is the fact most commonly cited when a suspension is eventually converted into erasure — the review record now documents it against her name .
Current Status
Kemenes is a suspended nurse. The six-month extension took effect at the end of 14 October 2026. The review panel found her insight unimproved and her engagement absent; unless that changes, the likely next step is a further review at which the panel will again weigh suspension against striking off, with the dishonesty finding and the non-engagement record both working against her .
Impact on Their Career/Life
A nurse with a proved finding that she falsified medication records to hide a tenfold insulin overdose now has a second consecutive suspension and a documented failure to engage with the process meant to rehabilitate her. The original dishonesty finding was the case’s anchor; the 2026 review added a year of non-engagement to it. Her registration now depends on producing, for the first time, the evidence of strengthened practice the review panel found missing .